Menopause specialists are concerned about how Canadian patients will be affected by Pfizer’s recent decision to stop supplying a vaginal cream and oral estrogen tablets in Canada, while continuing to offer them in the U.S.
asserted
patients → concern → U.S.
Physicians say they fear patients will have to contend with the ramifications of Pfizer’s decision, made public last week, to discontinue Premarin cream and tablets in Canada, prescribed to those navigating menopause symptoms.
asserted
patients → say → symptoms
Existing inventory is expected to last until next year.
asserted
inventory → exist → year
Premarin was first developed and approved in Canada in 1941 and Pfizer manufactures the global supply of the active ingredient in Brandon, Man.
asserted
Pfizer → develop → Brandon
It comes from the urine of pregnant mares in Manitoba and Saskatchewan.
asserted
It → come → Manitoba
Pfizer first notified Health Canada on Nov. 3 that it would stop supplying Premarin products, according to a federal drug-shortage database.
uncertain
it → notify → database
The cream is being discontinued immediately and pills will be available while inventory lasts, potentially until next June, according to notices on the database.
uncertain
inventory → discontinue → database
Pfizer said Premarin products were “commercially unsustainable” in Canada.
asserted
products → say → Canada
The company “considered a range of factors, including manufacturing and supply costs, the pricing and reimbursement environment, and the ability to maintain sustainable supply over the longer term,” said Sophie Morin, a spokesperson for Pfizer Canada, in an e-mail.
asserted
Morin → consider → mail
The federal database shows the Premarin cream has been in shortage four times since the beginning of 2025.
asserted
cream → show → 2025
In the U.S., demand has grown for menopause hormone therapy, including after the Food and Drug Administration initiated the removal of long-standing safety warnings on the treatments last November.
asserted
Administration → grow → treatments
Health Canada has not removed similar warnings on products here.
asserted
Canada → remove → products
In September, a report from Manulife Canada about its group benefits showed a 228-per-cent increase in hormone-replacement therapy claims over five years among women 45 to 54.
uncertain
report → show → women
Canadian obstetrician-gynecologist Jen Gunter wrote Wednesday on her blog that Pfizer’s decision should concern all Canadians.
asserted
decision → write → Canadians
“This isn’t just about Premarin,” she wrote.
asserted
she → write → Premarin
“Every Canadian who cares about access to medications need to be engaged and speak up.”
asserted
who → care → medications
In its cream form, Premarin allows for estrogen to be applied directly to vaginal tissue.
asserted
estrogen → allow → tissue
It is used to treat atrophic vaginitis, including drying of the vaginal walls, as well as shrinkage of the skin of the vagina and vulva.
asserted
It → use → vagina
It can also be used to address dyspareunia, which is pain or discomfort during intercourse.
asserted
which → use → intercourse
While there are some alternatives available, Dr. Gunter wrote that Premarin may be better for some patients in terms of side effects and efficacy.
uncertain
Premarin → be → effects
Also, physicians say stopping certain treatments can lead to a rebound of symptoms, such as hot flashes and vaginal irritation, and can set back patients in their menopause care.
asserted
stopping → say → care
A tube of Premarin cream in Canada typically retails for around $50 because of federal drug rules.
asserted
tube → retail → rules
By comparison, it retails for around $400 to $500 in the United States.
asserted
it → retail → States
Some patients can access the cream for a lower price if they have insurance coverage.
asserted
they → access → coverage
Rithvika Ramesh, a family physician in Toronto, said the discontinuation affects some of her patients.
asserted
discontinuation → say → patients
It is the only vaginal estrogen cream covered under the Ontario Drug Benefit program, she said.
asserted
she → cover → program
The drug funding plan covers the cost of certain medications for eligible residents.
asserted
plan → cover → residents
She said the vaginal cream has long been an important treatment option for patients experiencing genitourinary symptoms of menopause.
asserted
cream → say → menopause
Additionally, she said it is used to help prevent recurrent urinary tract infections.
asserted
it → say → infections
Dr. Ramesh said for older adults in particular, preventing UTIs can be life-saving, noting that a seemingly uncomplicated infection can progress to kidney infection, hospitalization and, sometimes, sepsis.
asserted
infection → say → infection
Sepsis is when the body’s immune system reacts in an extreme way to an infection and it can cause organs to shut down and in some cases, lead to death.
asserted
organs → react → death
“Access to effective vaginal estrogen is not simply a matter of quality of life but an important component of preventative health care,” Dr. Ramesh said.
asserted
Ramesh → say → care
Lily Barnes, a spokesperson for Ontario Health Minister Sylvia Jones, said vaginal estrogen products identified by the Canadian Menopause Society, including a vaginal ring, tablet and inserts, are still covered on the provincial drug formulary.
asserted
products → say → formulary
The Canadian Pharmacists Association has developed a resource for health care providers to manage supply changes, she added.
asserted
she → develop → changes
Dr. Ramesh said those who rely on the product may face additional out-of-pocket costs and could have to transition to a product that doesn’t adequately align with their symptoms, preferences and needs.
uncertain
that → say → symptoms
Dr. Gunter also voiced concerns about how the discontinuation will affect patients and wants the federal government to get involved in the matter.
asserted
government → voice → matter
“The federal government oversees drug approvals and international trade policies,” Dr. Gunter wrote.
asserted
Gunter → oversee → approvals
“It is legitimate to ask our elected officials and members of the Senate to find out why this is happening.”
asserted
this → ask → Senate
A spokesperson for federal Health Minister Marjorie Michel’s office said that Health Canada is assessing the effects of the discontinuation of Premarin on menopause hormone-therapy supply in Canada, and will act as needed to minimize the impact of shortages.
asserted
Canada → say → shortages